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ABSTRACT The skeletal muscle sodium channel mutant 11160V cosegregates with a disease phenotype producing
myotonic discharges (observed as muscle stiffness) that are worsened by elevated K+ levels but unaffected by cooling. The
11160V a-subunit was co-expressed with the B1-subunit in Xenopus oocytes. An electrophysiological characterization was
undertaken to examine the underlying biophysical characteristics imposed by this mutation. Two abnormalities were found.
1) The voltage dependence of steady-state fast inactivation was reduced in 11160V, which resulted in faster rates of
closed-state fast inactivation onset and recovery in 11160V compared with wild-type channels. 2) The rates of deactivation
were slower in 11160V than in wild-type channels. Using a computer-simulated model, the combination of both defects
elicited myotonic runs under conditions of elevated K+, consistent with the observed phenotype of the mutant.
INTRODUCTION
There are several inherited human diseases of muscle hy-
perexcitability. The diseases are grouped according to clin-
ical phenotype and exacerbating factors (Barchi, 1995; Can-
non, 1996; Ptacek and Griggs, 1996). Paramyotonia
congenita (PC), for example, is characterized by episodic
myotonia and, less frequently, muscle weakness that occurs
after muscle cooling. Hyperkalemic periodic paralysis
(HyPP) is a related disorder that can involve myotonia but
primarily results in periodic paralysis exacerbated by high
serum potassium. Sodium channel myotonia (SCM) is a
separate classification with aspects of both PC and HyPP,
specifically, myotonia without muscle weakness, often ex-
acerbated by K+ (Lerche et al., 1993; Ptacek et al., 1994)
and less frequently aggravated by cold (Heine et al., 1993).
PC, HyPP, and SCM are all caused by missense mutations
in voltage-gated human skeletal muscle sodium channel
(hSkMl) a-subunits. Some of these mutants have been
studied either in situ or in heterologous expression systems
(Barchi, 1995; Cannon, 1996; Ptacek and Griggs, 1996).
In addition to the clinical importance of understanding
the molecular basis of human diseases, biophysical studies
of disease-causing mutant channels provide a valuable op-
portunity to clarify relationships between ion channel struc-
ture, biophysical performance, and in vivo function. Recent
biophysical studies of muscle disease mutants have allowed
new insights into the structural basis of sodium channel fast
(Chahine et al., 1994; Wang et al., 1995; Ji et al., 1996) and
slow inactivation (Cummins and Sigworth, 1996) as well as
the physiology of muscle electrogenesis.
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Like both PC and HyPP, SCM results from mutations in
sodium channel regions with assigned functions. The SCM
mutant V1589M, for example, is in DIV-S6, a region of the
sodium channel linked to fast inactivation and drug binding
(McPhee et al., 1994, 1995). Two other SCM mutations
(G1306A/E) are in the DIII-IV linker crucial for fast inac-
tivation (Lerche et al., 1993; West et al., 1992). The fast
inactivation binding site is currently the object of intense
interest by several groups, whose work has suggested that
the binding site may consist of S4-5 linkers from several
domains (Tang et al., 1996; Tang and Kallen, 1997; Lerche
et al., 1997; Filatov et al., 1997; Smith et al., 1997). I1160V
is an isoleucine-to-valine substitution in the domain III
S4-5 linker that, like G1306A/E and V1589M, causes SCM
(Ptacek et al., 1994). II 160V is of particular interest because
it lies in a sodium channel region of emerging interest and
importance. I1 160V, however, has not been biophysically
characterized.
In this study, we expressed I1 160V and hSkMl wild-type
(WT) a-subunits, along with the (31-subunit, in Xenopus
oocytes and compared the resulting currents using on-cell
macropatches. On-cell macropatches of coexpressed a- and
,B1-subunits provide excellent voltage control and kinetic
stability, resulting in fast sodium currents that closely match
recordings from native channels. We examined the voltage
dependence of activation and voltage dependence and rates
of fast inactivation, slow inactivation, and deactivation. Our
results show that, compared with hSkMl WT, II 160V has
1) a decreased voltage sensitivity of fast inactivation at
negative potentials resulting in faster recovery from inacti-
vation and 2) slower deactivation. II 160V did not affect the
voltage dependence of activation, steady-state slow inacti-
vation, or rates of slow inactivation and did not cause a
persistent current. Computer simulations of muscle mem-
branes show that the combination of faster recovery from
fast inactivation, along with slowed deactivation, is suffi-
cient to cause potassium-sensitive myotonia, consistent with
the phenotype of SCM.
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MATERIALS AND METHODS
cDNA for the rat brain ,31-subunit was generously provided by L. Isom
(Isom et al., 1992).
Mutagenesis
Site-directed mutagenesis of hSkMI using a one-step recombinant poly-
merase chain reaction (PCR) strategy was performed to create the Il 160V
mutation. A forward primer (5'-GTG AAC GCC CTC CTA GGC GCC
ATC CCC TCC GTG ATG AAT GTG CTG CTT GTC T-3') spanning
nucleotides (nts) 3525-3576 and a reverse primer (5'-TAG AGG TAC
ATG TAG AG-3', nts 3882-3898) were used to create the mutation and
incorporate natural restriction sites for AvrH (nt 3537) and Sse83871 (nt
3794) in the final 373-bp product. Amplifications (20 cycles) were per-
formed using 20 ng of hSkM1 cDNA as template and Taq DNA polymer-
ase. Final products were purified by spin-column chromatography (Qiagen,
Chatsworth, CA) and digested with AvrII and Sse83871, and the resulting
257-bp fragment was ligated into the corresponding sites in the plasmid
pSP64T-hSkMl. The amplified region was sequenced entirely in the final
construct to verify the mutation and to exclude polymerase errors.
RNA preparation and injection
cDNAs for the WT and I1 160V hSkMl a-subunits were linearized with
EcoRl, and 13-subunit with HindIl. RNA from full-length 6.1-kb human
SkMl sodium channel a-subunit cDNA in pSP64T was synthesized in
vitro with SP6 polymerase. 13-Subunit cDNA in pBluescript was tran-
scribed in vitro with T3 polymerase. In vitro transcriptions were performed
on each clone. mMessage mMachine kits from Ambion (Austin, TX) were
used on 1 jig of each linearized clone template. RNA for injection was
precipitated and resuspended in 1 mM Tris-Cl, pH 6.5, at a concentration
of approximately 1 lig/,u. Equal volumes of a- and 13-subunit mRNA
(each at a concentration of approximately 1 p,g/,ul) were mixed together
before injection for both WT and mutant experiments.
Stage V-VI oocytes were surgically removed from female Xenopus
laevis (Nasco, Modesto, CA) anesthetized with 0.17% tricaine methane-
sulfonate (Sigma Chemical Co., St. Louis, MO). After surgery, frogs were
allowed to recover in isolation in a shallow tank of distilled water. After
verifying full recovery a few hours later, frogs were returned to the large
rearing tank. Theca and follicle cells were enzymatically removed from the
oocytes by gently agitating the oocytes in a solution containing (in mM):
96 NaCl, 2 KCI, 20 MgCl2, 5 HEPES, pH 7.4, with 2 mg/ml collagenase
(Sigma) for approximately 1 h. After enzymatic treatment, oocytes were
rinsed several times in a solution containing (in mM): 96 NaCl, 2 KCI, 20
MgCl2, 5 HEPES, pH 7.4, and then placed in sterile incubation media
containing (in mM): 96 NaCl, 2 KCI 2, 20 MgCl2, 1.8 CaCl2, 5 HEPES, 2.5
pyruvic acid, pH 7.4, with 1-5% horse serum (Irvine Scientific, Irvine, CA)
and 100 mg/L gentamycin sulfate at 18°C. Approximately 24 h after
enzymatic treatment, oocytes were individually injected with 50 nl of
mRNA, using a Drummond automatic injector, and then further incubated
in 60-mm disposable petri dishes with gentle agitation (approximately 60
rpm on a small rotary shaker) at 18°C until electrophysiological recording
3-14 days later. The incubation solution bathing the oocytes was changed
daily.
Electrophysiology
In preparation for macropatch recording, the vitelline membrane was
manually removed from oocytes after a short (2-5 min) exposure to a
hyperosmotic solution containing (in mM): 96 NaCl, 2 KCI, 20 MgCl2, 5
HEPES, 400 mannitol, pH 7.4. All macropatch recording was done in a
chamber containing (in mM): 96 NaCl, 88 KCI, 11 EGTA, 5 HEPES, pH
7.4. Aluminosilicate patch electrodes were pulled on a Sutter P-87, dipped
in melted dental wax to reduce capacitance, fire polished, and filled with
(in mM): 96 NaCl, 4 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES, pH 7.4.
Electrophysiological recordings were made using an EPC-9 patch-
clamp amplifier (HEKA, Lambrecht, Germany) and digitized at 5 KHz
(bandwidth before digitization was 1 MHz) via an ITC-16 interface (In-
strutech, Great Neck, NY). Voltage clamping and data acquisition were
controlled via Pulse software (HEKA) running on a Power Macintosh
7100/80. All data were software-low-pass-filtered at 5 KHz during acqui-
sition. Experimental bath temperature was maintained at 22 ± 0.2°C for all
experiments by using a peltier device controlled by an HCC-1OOA tem-
perature controller (Dagan, Minneapolis, MN). After seal formation,
patches were left on-cell for all recordings. On-cell patches were more
stable, allowing long-term recordings, and because of equal cytosolic and
extracellular [K+], showed no differences in sodium currents or voltage
dependence compared with excised inside-out patches. Where the voltage
dependence of inactivation was studied, the clamp control software (Pulse)
alternated prepulse potentials, such that prepulse potentials were delivered
as -160 mV, +10 mV, -155 mV, +5 mV, -150 mV, etc. over the
voltage range of -160 mV to + 10 mV in 5 mV steps. As described in the
text, prepulses were 500 ms long for steady-state fast inactivation and 1
min for steady-state slow inactivation. Holding potential was - 120 mV to
-150 mV. Leak subtraction was performed automatically by the software
using a p/4 protocol. Leak holding potential was -120 mV. Leak pulses
were always performed after the test pulse and sufficient time between
protocols was allowed to insure that the leak pulses would have no effect
on the data.
Analysis
Analysis and graphing were done using Pulsefit (HEKA) and Igor Pro
(Wavemetrics, Lake Oswego, OR), both run on a Power Macintosh 7100/
80. All statistically derived values in the text are given as mean ± standard
deviation (SD) and in figures as mean ± standard error of the mean (SEM).
Conductance-voltage curves were computed using the equation:
G = Imax/(Vm - Erev),
where G is conductance, Ima,, represents the peak test pulse current, Vm the
test pulse voltage, and Erev the measured reversal potential.
Steady-state activation and fast inactivation were fit by a Boltzmann
distribution, as follows:
Normalized current amplitude
= 1/1 + exp(-zeo(Vm
-VI2)/k7)),
where normalized current amplitude is measured during a variable-voltage
test pulse from a holding potential of - 150 mV (for steady-state activa-
tion) or during a test pulse to 0 mV after a variable-voltage prepulse (for
steady-state inactivation). Vm is the test pulse/prepulse potential, z is the
apparent valence, eo is the elementary charge, V1/2 is the midpoint voltage,
k is the Boltzmann constant, and T is absolute temperature.
Descriptions of test pulse inactivation rates, given as time constants (T),
were derived from fitting the monoexponential decay of individual currents
according to the function:
I(t) = ISS + a1 exp(-t/T),
where I(t) is current amplitude as a function of time, ISS is the steady-state
current, or asymptote (plateau amplitude), a, is the amplitude at time = 0
(time of peak current), and T is the time constant (in ms).
Time constants for the onset (and recovery) of inactivation were mea-
sured in the same way, except that fits were to peak current amplitude
versus prepulse (or interpulse) duration. Descriptions of first-order, two-
state reaction kinetics were derived by fitting t versus voltage curves
according to the following equation:
T(Vm) = 1/(kf + kb),
where r(Vm) represents the time constant of progression to equilibrium as
a function of membrane potential, kf is the rate of the forward reaction (not
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inactivated > inactivated), and kb is the rate of the backward reaction
(inactivated not inactivated).
kf = A exp + ((e(1 - d)(Vm - Vo))IkT)
kb = A exp - ((ed(Vm - Vo))/kl)
where A = 1/2 rate at VO, e = total reaction valence (in electronic charge),
d = fractional barrier distance, Vm = membrane potential (in mV), VO =
midpoint potential (in mV); k = Boltzmann constant, and T = absolute
temperature.
Muscle membrane simulations were performed with Simulation Control
Program (SCoP) 3.5 (Simulation Resources, Berrie Spring MI), using
quantitative methods originally developed by Hodgkin and Huxley (1952)
and subsequently adapted for mammalian skeletal muscle by Cannon et al.
(1993). Briefly, the simulated membrane potential varied as a result of
combined ionic sodium, potassium, and chloride (leak) currents. Sodium
channel conductance was a function of m3h gating, and potassium channel
conductance was a function of n4 gating, where m, h, and n parameters
were assumed to obey first-order kinetics, as described in Hodgkin and
Huxley (1952). The voltage dependence of the transitions of m, h, and n
were each defined by forward and backward rate constants according to the
formulations given as equations 10, 11, and 12 in Cannon et al. (1993). In
these equations, we used the gating parameters and conductances given in
Table 1 of Cannon et al. (1993), which they used to successfully simulate
human skeletal muscle excitability. Modified sodium channel fast inacti-
vation and deactivation in 1 160V mutant muscle fibers (this paper, Fig. 5,
B and D) was simulated by defining total INa = (0.5 * INa-WT) +
(0.5 * INa-Il 160V). Thus, 50% of simulated channels were WT, and 50%
were II 160V, as occurs in the autosomal dominant disease. INa-WT used
normal gating parameters obtained from rat and human skeletal muscle, as
given in Cannon et al. (1993). INa-Il 160V had fast inactivation recovery
rates multiplied by 1.75 and deactivation rates multiplied by 0.60. These
values were calculated based on the difference between WT and I1 160V
fast inactivation and deactivation at -70 mV. Forward and backward rates
were adjusted for temperature according to a QIO of 2.5. This QIO was
used for both WT and mutant channels.
RESULTS
Voltage dependence of activation and
fast inactivation
I1160V is associated with muscle hyperexcitability, which
could be due to changes in Na+ channel availability. Chan-
nel availability can occur as a result of shifts in the voltage
dependence of activation or steady-state fast inactivation as
previously observed for PC and HyPP mutants (Hayward et
al., 1996; Lerche et al., 1996; Yang et al., 1994; Richmond
et al., 1997). Therefore, these parameters were examined in
I1 160V.
The conductance-voltage relationship for I1 160V and
hSkMl WT is shown in Fig. 1 A. A test pulse potential to 0
mV was sufficient to activate approximately all channels,
with the appearance of measurable currents above -70 mV.
A Boltzmann distribution fit to each data set yielded
the following fit coefficients (mean ± SD): I1 160V,
V1/2 = -43.21 ± 6.11 mV and z = 3.44 ± 0.41; hSkMI
WT, V1/2 = -40.4 ± 7.74 mV and z = 3.68±.0.59 (where
V1/2 is the midpoint and e is the valence of the Boltzmann
distribution). These data showed no significant difference
between the voltage dependence of activation in I1 160V or
hSkM1 WT channels using Student's t-test.
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FIGURE 1 The conductance-voltage (G-V) relationship and steady-state
fast-inactivation curve for I1 160V and hSkMl WT. (A) The voltage de-
pendence of activation for I1 160V (n = 15) and hSkMl WT (n = 13) was
measured as the fraction of channels that open in response to a 10-ms test
pulse ranging between -90 and +20 mV from a Vhold of -150 mV
(average ± SEM). (B) The voltage dependence of steady-state fast inac-
tivation for I1 160V (n = 21) and hSkM1 WT (n = 13) was measured as
the fraction of activatable channels at 0 mV after a 500-ms prepulse
ranging between -160 and -40 mV (see protocol diagram, average ±
SEM).
Fig. 1 B shows the voltage dependence of steady-state
fast inactivation for I1 160V and hSkMl WT using a pre-
pulse duration of 500 ms (Richmond et al., 1997). Boltz-
mann fits yielded the following coefficients (mean ± SD):
11160V, V112 = -96.6 ± 8.2 mV and z = 3.06 + 0.46;
hSkMI WT, V112 = -95.3 ± 8.3 mV and z = 3.63 + 0.26.
These data reveal a significant difference in the valence of
fast inactivation (p = 0.02, Student's t-test), I1 160V show-
ing slightly lower voltage sensitivity. There was no signif-
icant difference in the midpoint of the steady-state fast
inactivation curves between I1 160V and hSkMl WT.
Kinetics of fast inactivation
The myotonic discharge characteristic of PC mutants has
been partially attributed to slowed open-state fast inactiva-
1 898 Biophysical Joumal
Biophysical Properties of 111 60V
tion and increased rates of recovery from fast inactivation
(Chahine et al., 1994; Yang et al., 1994; Hayward et al.,
1996). Fast inactivation kinetics were, therefore examined
in I1 160V. Fig. 2 A shows representative series of currents
evoked by test pulses between -90 and +20 mV. In most
current traces a single exponential function was sufficient to
fit the current decay. In some macropatches a very small
residual slow mode component was also observed. The time
constants of inactivation plotted in Fig. 2 B, derived from
single exponential fits to the test pulse current decay,
showed no significant difference between 11160V and
hSkMl WT.
Evidence for a persistent current was assessed by mea-
suring the steady-state current amplitude (ISS) derived from
the fit expressed as a percentage of the peak current ampli-
tude in each trace. Persistent current was negligible in both
I1 160V and hSkMl WT, with average values between -40
to +20 mV of 0.2 ± 0.36% and 0.55 ± 0.12% (mean ±
SD), respectively. There was no significant difference be-
tween persistent current values obtained for hSkM 1 WT and
I1160V at any of these voltages.
To examine the kinetics of closed-state fast inactivation,
prepulses of varying duration between -100 mV and -60
mV were used, before a test pulse at 0 mV as exemplified
in the right panel of Fig. 2 C for a prepulse of -80 mV.
Recovery from fast inactivation (exemplified in the left
panel of Fig. 2 C) was examined by fast inactivating all
channels with a 500-ms pulse to 0 mV before a prepulse of
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FIGURE 2 Inactivation kinetics of I1 160V and hSkMl WT sodium channels. (A) Representative macropatch sodium currents evoked by test pulses from
-150 mV to a series of potentials ranging from -90 mV to +20 mV for hSkM1-WT and I1 160V sodium channels. (B) Single exponentials were fit to
test pulse decay at voltages from -50 mV to +40 mV to derive the time constants for open-state fast inactivation (average ± SEM; n for I1 160V ranging
from 15 to 22 and hSkMl WT ranging from 5 to 10 for voltages -50 mV to +40 mV). (C, left panel) Normalized currents for fast-inactivation recovery
at -150 mV in I1 160V (n = 9) and hSkM1 WT (n = 10) channels (average ± SEM). Current values were obtained from 0-mV test pulses after a 150-mV
interpulse of varying duration, where the interpulse followed a 500-ms step to 0 mV, which fully inactivated all channels (see protocol diagram). (C, right
panel) Averaged, normalized currents for the onset of closed-state fast inactivation at -80 mV for I1 160V (n = 5) and hSkMl WT (n = 7; average ±
SEM). Normalized current amplitudes were derived from 0-mV test pulses after a -80 mV prepulse of increasing duration (see protocol diagram). Fit lines
were derived by fitting a single exponential to the normalized, averaged plots of 0-mV test pulse amplitude versus prepulse duration. (D) The time constants
of closed-state fast inactivation (n for II 160V ranging from 4 to 5 and for hSkMl WT ranging from 5 to 9 for voltages from -100 mV to -60 mV) and
test pulse fast inactivation (-50 mV through +60 mV, n given in B) and recovery (n for II 160V ranging from 3 to 9 and for hSkMl WT ranging from
5 to 10 for voltages from -150 mV to -110 mV). I1 160V (0) and hSkMl WT (-) are plotted as a function of voltage (average ± SEM). Time constants
for closed-state fast inactivation and recovery were derived from exponential fits to 0-mV test pulses versus duration for each voltage on individual
macropatches. Fit lines to the ensemble time constant data are predictions of a first-order Eyring reaction model.
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varying duration to a recovery potential within the range
-150 to -110 mV, followed by a test pulse to 0 mV to
assay the fraction of recovered channels. Averaged time
constants derived from single exponential fits to data as in
Fig. 2 C are plotted in Fig. 2 D over the entire voltage range
tested (-150 to -60 mV), along with the open-state fast
inactivation T values (between -50 mV and +40 mV). A
two-state (not inactivated to inactivated) first-order Eyring
reaction model was used to fit the averaged time constant
data for II 160V and hSkMl WT. The coefficients of this fit
gave a maximal time constant of 7.04 ms for I1 160V vs.
11.8 ms for hSkMl WT, showing that the fast inactivation
time constants around the peak of the reaction are faster in
I1 160V.
At potentials negative to -100 mV, the rates of inacti-
vation in I1 160V were not significantly different from
hSkMl WT. Statistical analysis (t-test) of the time constants
(mean ± SD) of the inactivation bell-shaped curve between
-90 mV and -70 mV confirmed that the average values
over this range were significantly different for II 160V
compared with wild-type channels.
As previously demonstrated (Featherstone et al., 1996),
the rates of inactivation derived from the fast inactivation
onset and recovery protocols at the same voltages overlap,
as these rates reflect the progress of the inactivation reaction
toward equilibrium. Therefore, time constants graphed in
the bell-shaped curve reflect either fast inactivation or re-
covery depending on the initial state of the channel, i.e.,
either initially inactivated in the recovery protocol or ini-
tially not inactivated in the onset protocol. After the peak of
an action potential, time constants would largely reflect
recovery from inactivation.
Deactivation kinetics
It has been shown that deactivation rates are also affected in
several PC mutants (Hayward et al., 1996; Ji et al., 1996;
Featherstone et al., submitted). In the PC mutants R1440P
and R1440C, which have identical fast inactivation rates,
the degree of slowing of deactivation corresponds to the
severity of the disease phenotype (Featherstone et al., sub-
mitted). Furthermore, inclusion of slowed deactivation rates
in a muscle simulation demonstrated that deactivation is an
important contributor to the temperature sensitivity of mus-
cle hyperexcitability in these PC mutants (Featherstone et
al., submitted).
To measure the deactivation rates in I1 160V and hSkMl
WT, channels were initially opened with a brief step (0.5
ms) to +50 mV before command potentials ranging from
-120 to -30 mV, which produced tail currents (see pro-
tocol diagram in Fig. 3 A). Fig. 3 A shows representative
examples of tail currents at -80 mV for I1 160V and hSkMl
WT. At all potentials tested, the tail current decay in I1 160V
(mean ± SD) was significantly slower than hSkMl WT
using Student's t-test (Fig. 3 B).
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FIGURE 3 Deactivation rates of II 160V and hSkMl WT. (A) Typical
tail currents during a step to -60 mV, after a brief (0.5-ms) channel-
opening pulse to +50 mV for 11160V and hSkMl WT (see protocol
diagram in figure). (B) Single exponentials were fit to tail current decays
to derive the average ± SEM time constants of deactivation for I1160V
(n = 12) and hSkMl WT (n = 8) over the voltage range shown.
Fast inactivation has been shown to contribute to tail
current decay (Aldrich and Stevens, 1987). However, using
the IFM to QQQ mutation of the skeletal muscle sodium
channel we know that contributions to tail currents would
only occur at potentials more positive than -80 mV (Feath-
erstone et al., submitted). At voltages more negative than
-80 mV, the extremely significant differences in deactiva-
tion rates in I1160V compared with hSkMl WT are un-
equivocally due to differences in deactivation rates. At more
positive potentials, open-state fast inactivation rates for
II 160V and hSkMl WT are identical (see Fig. 2 B). There-
fore, the differences in decay rates over this range, regard-
less of any contribution due to fast inactivation decay, can
also be attributed to a significant slowing of deactivation in
I1 160V.
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Steady-state slow inactivation
In the HyPP mutant T704M, it has been shown that the rates
and extent of slow inactivation are affected (Cummins and
Sigworth, 1996; Hayward et al., 1997). Less complete slow
inactivation in combination with a small persistent current
in T704M has been speculated to account for the prolonged
muscle depolarization and resultant muscle paralysis char-
acteristic of the HyPP phenotype (Cummins and Sigworth,
1996). In the PC mutant Ti 313M, in which muscle paralysis
is less common, persistent currents have been observed in
some studies (Tahmoush et al., 1994; Hayward et al., 1996)
although not in others (Richmond et al., 1997; Yang et al.,
1994), but steady-state slow inactivation is not affected. As
20% of both hSkMl WT and PC mutant channels do not
slow inactivate at steady state (Richmond et al., 1997), a
persistent current could still bring about some degree of
muscle paralysis. 1 160V is not associated with muscle
weakness, and in our study there is also no evidence of a
persistent current. However, it is possible that slow inacti-
vation could still be affected in I1 160V without any appar-
ent phenotypic consequence. Due to the similar location of
I1 160V in DIII with respect to T704M in DII (Cannon,
1996), it was important to examine slow inactivation in
I1 160V.
To measure steady-state slow inactivation, a prepulse of
60 s was followed by a 5-ms step to -150 mV (to recover
channels from fast inactivation) before a 0-mV test pulse to
assay for slow inactivation. A 30-s step back to -150 mV
was included between trials to fully recover channels from
slow inactivation (Featherstone et al., 1996). As shown in
Fig. 4 A, steady-state slow inactivation in I1 160V assessed
with Student's t-test was not significantly different from
hSkMl WT.
Slow inactivation kinetics
Rates of slow inactivation were measured at prepulse volt-
ages ranging from -90 to 0 mV. A prepulse of increasing
duration (0-60 s) was used to induce inactivation followed
by a 5-ms step to -150 mV (to recover fast-inactivated
channels) before a test pulse to assay for the fraction of
available channels. A 30-s step back to -150 mV was used
between trials to fully recover all channels from slow inac-
tivation. At all potentials, slow inactivation was complete
by 60 s. A single exponential fit to these plots yielded the
time constants of slow inactivation for each prepulse volt-
age from -90 to 0 mV graphed in Fig. 4 B.
The time constants of recovery from slow inactivation
were measured at prepulses between -150 and -110 mV.
A 60-s conditioning pulse to 0 mV was used to maximally
slow inactivate all channels, followed by a prepulse of
varying duration; a 5-ms step to -150 mV selectively
recovered all fast-inactivated channels, so that a final test
pulse assayed for the fraction of slow-inactivated channels
only. A 30-s step back to -150 mV between trials was used
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FIGURE 4 Slow inactivation kinetics and steady-state voltage depen-
dence of I1160V and hSkMI WVT. (A) Steady-state slow inactivation
plotted as a function of voltage for II 160V (n = 9) and hSkM1 WT (n =
23; average and SEM). At each voltage, a prepulse of 60 s was followed by
a 5-ms step to - 150 mV to selectively recover fast inactivation before a
test pulse to assay for slow inactivation and a 30-s step back to -150 mV
to recover from all inactivation (see protocol diagram in A). (B) Time
constants of slow inactivation plotted as a function of voltage for I1 160V
and hSkM 1 WT. The onset of slow inactivation was measured at prepulse
voltages ranging from -90 to 0 mV (n for I1 160V ranging from 4 to 11
and for hSkM1 WT ranging from 4 to 12). A prepulse of varying duration
(0 to 60 s) was used to induce inactivation followed by a 5-ms step to -150
mV (to recover fast-inactivated channels) before a test pulse to assay for
available channels. A 30-s step back to -150 mV was used to recover from
slow inactivation (see right protocol diagram in B). The time constants of
recovery from slow inactivation were measured at prepulses between -150
and -110 mV (n for 11160V ranging from 3 to 5 and for hSkM1 WT
ranging from 3 to 8). A 60-s conditioning pulse to 0 mV was used to
maximally slow-inactivate all channels, followed by a prepulse of varying
duration; a 5-ms step to -150 mV selectively recovered all fast-inactivated
channels, so that a final test pulse assayed for slow inactivated channels
only. A 30 s step back to -150 mV was used to recover from residual slow
inactivation (see left protocol diagram in B). Slow inactivation onset and
recovery time constants were measured by fitting single exponentials to
plots of peak test pulse current amplitude versus prepulse duration. In each
case, slow inactivation was best fit by a single exponential.
to recover all channels from slow inactivation. Plots of
prepulse duration versus test pulse current amplitude were
fit with a single exponential to determine the time constants
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of slow-inactivation recovery plotted over the range -150
to -110 mV in Fig. 4 B.
The kinetics of slow inactivation were not significantly
different between I1 160V and hSkMl WT with the excep-
tion of time constants at -150 mV.
Computer simulations of biophysical parameters
observed in 11160V and hSkMl WT
To test the effects of the I1 160V inactivation and deactiva-
tion defects, voltage recordings from an excitable muscle
membrane were computer simulated (Fig. 5). For these
simulations, standard Hodgkin-Huxley equations were used,
except that rates, concentrations, conductances, and QIO
values from rat and human skeletal muscle were incorpo-
rated (see Table 1 of Cannon et al., 1993; Hayward et al.,
1996). The rate of recovery from fast inactivation for
I1 160V was increased to 1.75 of the hSkMl WT rate, and
the deactivation rate was decreased to 0.6 that of hSkMl
WT based on the presented biophysical observations using
the time constants at -70 mV (see Figs. 2 and 3).
At normal K+ levels (4 mM) a 20-ms, 160 uA/cm2
stimulus elicited a single action potential in both the hSkMl
WT and II 160V simulations (Fig. 5, A and B, respectively).
When external K+ was elevated to 12 mM, the II 160V
mutant produced an action potential barrage (Fig. 5 D),
whereas hSkMl WT was unaffected (Fig. 5 C). The myo-
tonia was observed only when both deactivation and fast-
inactivation recovery were altered to reflect the observa-
tions in Figs. 2 and 3. Either defect alone was insufficient to
produce myotonia in the simulation.
In similar simulations of PC mutants R1440C and
R1440P, which exhibit cold-induced myotonia, defects in
WT I 160V
4 mM K+
12 mMK+
FIGURE 5 A computer simulation incorporating the biophysical defects
observed in Ii 160V compared with hSkM 1 WT. The rate of recovery from
fast inactivation for I1 160V was increased to 1.75 of the hSkMl WT rate,
and the deactivation rate was decreased to 0.6 that of hSkM1 WT based on
the presented biophysical observations (see Figs. 2 and 3). A simulated
membrane response to a 20-ms, 160 ,uA/cm2 stimulus at 37°C elicited a
single action potential in both hSkMl-WT (A) and I1 160V (B) at physio-
logical external K+ levels (4 mM) and at elevated K+ (12 mM).
deactivation and open-state fast inactivation produced myo-
tonic runs at lowered temperatures (from 37°C to 27°C; see
Featherstone et al., submitted). Reducing the temperature to
27°C in the I1160V simulation did not produce muscle
hyperexcitability at normal K+ levels, consistent with the
lack of temperature sensitivity of the I1 160V phenotype.
DISCUSSION
The hSkMl sodium channel mutant I1 160V is associated
with SCM, a disease in which K+-aggravated myotonia
occurs in the absence of muscle weakness (Ptacek et al.,
1994). To gain insights into the underlying biophysical
disruptions that account for SCM, the I1 160V mutant was
constructed and examined electrophysiologically.
We have shown that the I1 160V mutation slows deacti-
vation and lowers voltage sensitivity of fast inactivation
compared with WT. Within physiologically relevant voltage
ranges (approximately -90 mV to +40 mV), the lowered
voltage dependence would speed recovery from fast inacti-
vation after an action potential. This, in combination with
slowed deactivation, results in K+-sensitive, but not cold-
sensitive, myotonia in computer simulations of a muscle
membrane. In the model, we presumed no effect of potas-
sium on sodium channel gating.
In addition to I1 160V, three other hSkMl mutants
(G1306A, G1306E, and V1589M) have been linked to the
SCM phenotype (Heine et al., 1993; Lerche et al., 1993;
Ptacek and Griggs, 1996). Variations in temperature sensi-
tivity (Heine et al., 1993) and incomplete assessment of K+
sensitivity among the SCM mutants (Ptacek and Griggs,
1996) complicate any interpretation of common biophysical
observations that may account for the SCM phenotype. In
addition, the biophysical data for each of the four mutants is
presently incomplete. However, three of the four mutants
have been shown to have slowed deactivation (II 160V,
G1306A, and G1306E; Mitrovic et al., 1995). Deactivation
in the fourth mutant, V1589M, has not yet been assessed.
Additionally, recovery from fast inactivation is faster in all
four mutants (Mitrovic et al., 1994, 1995), although in
G1306A/E, the predominant effect was at unphysiologically
negative potentials (Mitrovic et al., 1995). It is tempting to
speculate that the myotonia common to all four mutants is
dependent on the occurrence of both slowed deactivation
and faster rates of recovery from inactivation. However,
several of the SCM mutants have additional defects that
would also predict hyperexcitability. For example, G1306A
and G1306E show slowed rates of open-state fast inactiva-
tion (Mitrovic et al., 1995). Furthermore, V1589M and
G1306E have evidence of increased late openings, seen as
persistent current (Mitrovic et al., 1994, 1995). Both of
these parameters could augment excitability and perhaps
explain differences in the degree of myotonia among mu-
tants and the additional temperature sensitivity of V1589M.
A common finding in all four SCM mutants is the ab-
sence of muscle weakness (Ptacek and Griggs, 1996). In
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HyPP, muscle weakness is attributed to a defect in slow
inactivation in conjunction with a persistent current (Cum-
mins and Sigworth, 1996). Consistent with this interpreta-
tion, I1 160V has neither persistent current nor slow inacti-
vation defects, which accounts for the lack of muscle
weakness. Both G1306E and V1589M have been reported
to have persistent currents, but slow inactivation has not
been investigated. If a slow inactivation defect is a neces-
sary prerequisite of mutants exhibiting muscle weakness,
then a prediction would be that none of the SCM mutants
would have slow inactivation defects.
The subtle biophysical changes resulting from the
I1160V mutation appear to be able to account for the
disease phenotype. However, the importance of the isoleu-
cine at position 1160 to normal sodium channel function
remains unclear. We can speculate, based on our results,
that the slower deactivation rates in the I1160V mutation
might reflect slower inward S4 translocations, which would
increase the likelihood that the binding site would be avail-
able for closed-state fast inactivation to occur, thus reducing
the apparent valence of fast inactivation.
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